Predictors of Progression From Impaired Glucose Tolerance to NIDDM: An Analysis of Six Prospective Studies
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Risk factors associated with the progression from impaired glucose tolerance (IGT) to NIDDM were examined in data from six prospective studies. IGT and NIDDM were defined in all studies by World Health Organization (WHO) criteria, and baseline risk factors were measured at the time of first recognition of IGT. The studies varied in size from 177 to 693 participants with IGT, and included men and women followed from 2 to 27 years after the recognition of IGT. Across the six studies, the incidence rate of NIDDM was 57.2/1,000 person-years and ranged from 35.8/1,000 to 87.3/1,000 person-years. Although baseline measures of fasting and 2-h postchallenge glucose levels were both positively associated with NIDDM incidence, incidence rates were sharply higher for those in the top quartile of fasting plasma glucose levels, but increased linearly with increasing 2-h postchallenge glucose quartiles. Incidence rates were higher among the Hispanic, Mexican-American, Pima, and Nauruan populations than among Caucasians. The effect of baseline age on NIDDM incidence rates differed among the studies; the rates did not increase or rose only slightly with increasing baseline age in three of the studies and formed an inverted U in three studies. In all studies, estimates of obesity (including BMI, waist-to-hip ratio, and waist circumference) were positively associated with NIDDM incidence. BMI was associated with NIDDM incidence independently of fasting and 2-h post challenge glucose levels in the combined analysis of all six studies and in three cohorts separately, but not in the three studies with the highest NIDDM incidence rates. Sex and family history of diabetes were generally not related to NIDDM progression. This analysis indicates that persons with IGT are at high risk and that further refinement of risk can be made by other simple measurements. The ability to identify persons at high risk of NIDDM should facilitate clinical trials in diabetes prevention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Harris, M. I., Hadden, W. C., Knowler, W. C., & Bennett, P. H. (1987) · Diabetes · doi:10.2337/diab.36.4.523 · Cited by 1,096
Self-citationDiabetes Mellitus: Report of a WHO Study Group.
(1986) · Annals of Internal Medicine · doi:10.7326/0003-4819-104-4-597_2 · Cited by 1,022
Ohlson, L. O., Larsson, B., Svärdsudd, K., Welin, L., Eriksson, H., Wilhelmsen, L., Björntorp, P., & Tibblin, G. (1985) · Diabetes · doi:10.2337/diab.34.10.1055 · Cited by 1,020
KNOWLER, W. C., BENNETT, P. H., HAMMAN, R. F., & MILLER, M. (1978) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112648 · Cited by 601
Self-citationDiabetes mellitus in the Pima Indians: Incidence, risk factors and pathogenesis
Knowler, W. C., Pettitt, D. J., Saad, M. F., & Bennett, P. H. (1990) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610060101 · Cited by 578
Self-citationThe natural history of impaired glucose tolerance in the Pima Indians
Saad, M. F., Knowler, W. C., Pettitt, D. J., Nelson, R. G., Mott, D. M., & Bennett, P. H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198812083192302 · Cited by 413
Self-citationHaffner, S. M., Stern, M. P., Mitchell, B. D., Hazuda, H. P., & Patterson, J. K. (1990) · Diabetes · doi:10.2337/diab.39.3.283 · Cited by 397
Haffner, S. M., Stern, M. P., Mitchell, B. D., Hazuda, H. P., & Patterson, J. K. (1990) · Diabetes · doi:10.2337/diabetes.39.3.283 · Cited by 397
Risk factors for worsening to diabetes in subjects with impaired glucose tolerance
Kadowaki, T., Miyake, Y., Hagura, R., Akanuma, Y., Kajinuma, H., Kuzuya, N., Takaku, F., & Kosaka, K. (1984) · Diabetologia · doi:10.1007/bf00252262 · Cited by 316
Haffner, S. M., Miettinen, H., Gaskill, S. P., & Stern, M. P. (1995) · Diabetes · doi:10.2337/diab.44.12.1386 · Cited by 303
Cited by
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Protection from obesity-induced insulin resistance in mice lacking TNF-α function
Uysal, K. T., Wiesbrock, S. M., Marino, M. W., & Hotamisligil, G. S. (1997) · Nature · doi:10.1038/39335 · Cited by 2,234
The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes
Altshuler, D., Hirschhorn, J. N., Klannemark, M., Lindgren, C. M., Vohl, M.-C., Nemesh, J., Lane, C. R., Schaffner, S. F., Bolk, S., Brewer, C., et al. (2000) · Nature Genetics · doi:10.1038/79216 · Cited by 1,766
Prevalence of impaired glucose tolerance among children and adolescents with marked obesity
Sinha, R., Fisch, G., Teague, B., Tamborlane, W. V., Banyas, B., Allen, K., Savoye, M., Rieger, V., Taksali, S., Barbetta, G., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012578 · Cited by 1,709
Effectiveness of brief alcohol interventions in primary care populations
Kaner, E. F., Beyer, F. R., Muirhead, C., Campbell, F., Pienaar, E. D., Bertholet, N., Daeppen, J. B., Saunders, J. B., & Burnand, B. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004148.pub4 · Cited by 1,665
Pereira, M. A., Kartashov, A. I., Ebbeling, C. B., Van Horn, L., Slattery, M. L., Jacobs, D. R., & Ludwig, D. S. (2005) · The Lancet · doi:10.1016/s0140-6736(04)17663-0 · Cited by 1,348
Gillies, C. L., Abrams, K. R., Lambert, P. C., Cooper, N. J., Sutton, A. J., Hsu, R. T., & Khunti, K. (2007) · BMJ · doi:10.1136/bmj.39063.689375.55 · Cited by 1,171
“People with impaired glucose tolerance have a high risk of developing type 2 diabetes,”
BackgroundFranz, M. J., Bantle, J. P., Beebe, C. A., Brunzell, J. D., Chiasson, J.-L., Garg, A., Holzmeister, L. A., Hoogwerf, B., Mayer-Davis, E., Mooradian, A. D., et al. (2002) · Diabetes Care · doi:10.2337/diacare.25.1.148 · Cited by 1,165
Vazquez, G., Duval, S., Jacobs, D. R., & Silventoinen, K. (2007) · Epidemiologic Reviews · doi:10.1093/epirev/mxm008 · Cited by 976
“Edelstein (56) Baltimore Longitudinal Study”
BackgroundInfluentialEpidemiology of Obesity and Diabetes and Their Cardiovascular Complications
Bhupathiraju, S. N., & Hu, F. B. (2016) · Circulation Research · doi:10.1161/circresaha.115.306825 · Cited by 945
Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects
Carlsson, L. M. S., Peltonen, M., Ahlin, S., Anveden, Å., Bouchard, C., Carlsson, B., Jacobson, P., Lönroth, H., Maglio, C., Näslund, I., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1112082 · Cited by 794
Pioglitazone for Diabetes Prevention in Impaired Glucose Tolerance
DeFronzo, R. A., Tripathy, D., Schwenke, D. C., Banerji, M., Bray, G. A., Buchanan, T. A., Clement, S. C., Henry, R. R., Hodis, H. N., Kitabchi, A. E., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1010949 · Cited by 766
Stern, M. P., Williams, K., González-Villalpando, C., Hunt, K. J., & Haffner, S. M. (2004) · Diabetes Care · doi:10.2337/diacare.27.11.2676 · Cited by 735
(1999) · Diabetes Care · doi:10.2337/diacare.22.4.623 · Cited by 725
The spectrum of neuropathy in diabetes and impaired glucose tolerance
Sumner, C. J., Sheth, S., Griffin, J. W., Cornblath, D. R., & Polydefkis, M. (2003) · Neurology · doi:10.1212/wnl.60.1.108 · Cited by 708
Geiss, L. S., Wang, J., Cheng, Y. J., Thompson, T. J., Barker, L., Li, Y., Albright, A. L., & Gregg, E. W. (2014) · JAMA · doi:10.1001/jama.2014.11494 · Cited by 672
Effect of valsartan on the incidence of diabetes and cardiovascular events
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001121 · Cited by 660
The many faces of diabetes: a disease with increasing heterogeneity
Tuomi, T., Santoro, N., Caprio, S., Cai, M., Weng, J., & Groop, L. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62219-9 · Cited by 652
Gong, Q., Zhang, P., Wang, J., Ma, J., An, Y., Chen, Y., Zhang, B., Feng, X., Li, H., Chen, X., et al. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30093-2 · Cited by 615
The Diabetes Prevention Program Research Group (2005) · Diabetes Care · doi:10.2337/diacare.28.4.888 · Cited by 572
“2 years from the start of the study in June 1996 through 31 July 2001, a period 4 months longer than that reported previously (1).”
BackgroundThe Prevention or Delay of Type 2 Diabetes
American Diabetes Association, & National Institute of Diabetes, D. A. K. D. (2003) · Diabetes Care · doi:10.2337/diacare.26.2007.s62 · Cited by 519
Weiss, R., Dufour, S., Taksali, S. E., Tamborlane, W. V., Petersen, K. F., Bonadonna, R. C., Boselli, L., Barbetta, G., Allen, K., Rife, F., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14364-4 · Cited by 499
The Prevention or Delay of Type 2 Diabetes
American Diabetes Association (2002) · Diabetes Care · doi:10.2337/diacare.25.4.742 · Cited by 489
Effect of nateglinide on the incidence of diabetes and cardiovascular events
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001122 · Cited by 477
Austin, S. B., Melly, S. J., Sanchez, B. N., Patel, A., Buka, S., & Gortmaker, S. L. (2005) · American Journal of Public Health · doi:10.2105/ajph.2004.056341 · Cited by 457
The Diabetes Prevention Program Research Group (2005) · Diabetes · doi:10.2337/diabetes.54.8.2404 · Cited by 446
Importance of Weight Management in Type 2 Diabetes: Review with Meta-analysis of Clinical Studies
Anderson, J. W., Kendall, C. W. C., & Jenkins, D. J. A. (2003) · Journal of the American College of Nutrition · doi:10.1080/07315724.2003.10719316 · Cited by 448
Risk Factors for Type 2 Diabetes Mellitus
Fletcher, B., Gulanick, M., & Lamendola, C. (2002) · The Journal of Cardiovascular Nursing · doi:10.1097/00005082-200201000-00003 · Cited by 397
Predictors of Changes in Glucose Tolerance Status in Obese Youth
Weiss, R., Taksali, S. E., Tamborlane, W. V., Burgert, T. S., Savoye, M., & Caprio, S. (2005) · Diabetes Care · doi:10.2337/diacare.28.4.902 · Cited by 378
Reduction in the Incidence of Type 2 Diabetes With Lifestyle Intervention or Metformin
(2003) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000055759.75837.e7 · Cited by 377
Lyssenko, V., Almgren, P., Anevski, D., Perfekt, R., Lahti, K., Nissén, M., Isomaa, B., Forsen, B., Homström, N., Saloranta, C., et al. (2005) · Diabetes · doi:10.2337/diabetes.54.1.166 · Cited by 368
Diet, nutrition and the prevention of type 2 diabetes
Steyn, N., Mann, J., Bennett, P., Temple, N., Zimmet, P., Tuomilehto, J., Lindström, J., & Louheranta, A. (2004) · Public Health Nutrition · doi:10.1079/phn2003586 · Cited by 367
Heymsfield, S. B., Segal, K. R., Hauptman, J., Lucas, C. P., Boldrin, M. N., Rissanen, A., Wilding, J. P. H., & Sjöström, L. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.9.1321 · Cited by 358
What is the best predictor of future type 2 diabetes
Abdul-Ghani, M. A., Williams, K., DeFronzo, R. A., & Stern, M. (2007) · Diabetes Care · doi:10.2337/dc06-1331 · Cited by 355
Ross, R., Berentzen, T., Bradshaw, A. J., Janssen, I., Kahn, H. S., Katzmarzyk, P. T., Kuk, J. L., Seidell, J. C., Snijder, M. B., Sørensen, T. I. A., et al. (2008) · Obesity Reviews · doi:10.1111/j.1467-789x.2007.00411.x · Cited by 354
Long-term non-pharmacological weight loss interventions for adults with type 2 diabetes mellitus
Norris, S. L., Zhang, X., Avenell, A., Gregg, E., Brown, T., Schmid, C. H., & Lau, J. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004095.pub2 · Cited by 351
Meigs, J. B., Muller, D. C., Nathan, D. M., Blake, D. R., & Andres, R. (2003) · Diabetes · doi:10.2337/diabetes.52.6.1475 · Cited by 338
Self-citationThe Diabetes Prevention Program Research Group (2005) · Diabetes · doi:10.2337/diabetes.54.5.1566 · Cited by 333
Saaristo, T., Peltonen, M., Lindström, J., Saarikoski, L., Sundvall, J., Eriksson, J. G., & Tuomilehto, J. (2005) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2005.011 · Cited by 331
Holman, R. R., Coleman, R. L., Chan, J. C. N., Chiasson, J.-L., Feng, H., Ge, J., Gerstein, H. C., Gray, R., Huo, Y., Lang, Z., et al. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30309-1 · Cited by 323
Jensen, C. C., Cnop, M., Hull, R. L., Fujimoto, W. Y., Kahn, S. E., & the American Diabetes Association GENNID Study Group (2002) · Diabetes · doi:10.2337/diabetes.51.7.2170 · Cited by 312
Müller, S., Martin, S., Koenig, W., Hanifi-Moghaddam, P., Rathmann, W., Haastert, B., Giani, G., Illig, T., Thorand, B., & Kolb, H. (2002) · Diabetologia · doi:10.1007/s00125-002-0829-2 · Cited by 311
“Since not all individuals with IGT progress to Type II diabetes [17, 18, 19] an increase in systemic IL-6 concentrations seems to be associated with IGT rather than with incident Type II diabetes.”
BackgroundLifestyle and the Prevention of Type 2 Diabetes: A Status Report
Galaviz, K. I., Narayan, K. M. V., Lobelo, F., & Weber, M. B. (2018) · American Journal of Lifestyle Medicine · doi:10.1177/1559827615619159 · Cited by 305
Prediabetes and Cardiovascular Disease
Brannick, B., & Dagogo-Jack, S. (2018) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2017.10.001 · Cited by 293
Gillies, C. L., Lambert, P. C., Abrams, K. R., Sutton, A. J., Cooper, N. J., Hsu, R. T., Davies, M. J., & Khunti, K. (2008) · BMJ · doi:10.1136/bmj.39545.585289.25 · Cited by 290
Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia
Richter, B., Hemmingsen, B., Metzendorf, M.-I., & Takwoingi, Y. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012661.pub2 · Cited by 283
The metabolic consequences of childhood obesity
Weiss, R., & Caprio, S. (2005) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2005.04.009 · Cited by 280
Appropriateness of waist circumference and waist-to-hip ratio cutoffs for different ethnic groups
Lear, S. A., James, P. T., Ko, G. T., & Kumanyika, S. (2010) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2009.70 · Cited by 276
Beyond fertility: polycystic ovary syndrome and long-term health
Cooney, L. G., & Dokras, A. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.08.021 · Cited by 270
Role of Insulin Resistance and Lipotoxicity in Non-Alcoholic Steatohepatitis
Cusi, K. (2009) · Clinics in Liver Disease · doi:10.1016/j.cld.2009.07.009 · Cited by 266
The prevention of type 2 diabetes
F. T. D. P. P. R. G., Crandall, J. P., Knowler, W. C., Kahn, S. E., Marrero, D., Florez, J. C., Bray, G. A., Haffner, S. M., Hoskin, M., & Nathan, D. M. (2008) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0843 · Cited by 261
Self-citationThe burden of type 2 diabetes: are we doing enough?
Zimmet, P. (2003) · Diabetes & Metabolism · doi:10.1016/s1262-3636(03)72783-9 · Cited by 260
Eddy, D. M., & Schlessinger, L. (2003) · Diabetes Care · doi:10.2337/diacare.26.11.3093 · Cited by 260
Anjana, R. M., Shanthi Rani, C. S., Deepa, M., Pradeepa, R., Sudha, V., Divya Nair, H., Lakshmipriya, N., Subhashini, S., Binu, V. S., Unnikrishnan, R., et al. (2015) · Diabetes Care · doi:10.2337/dc14-2814 · Cited by 259
Preservation of β-Cell Function: The Key to Diabetes Prevention
DeFronzo, R. A., & Abdul-Ghani, M. A. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0246 · Cited by 247
Is There a Role for ??-Glucosidase Inhibitors in the Prevention of Type 2 Diabetes Mellitus?
Scheen, A. J. (2003) · Drugs · doi:10.2165/00003495-200363100-00002 · Cited by 242
Swinburn, B. A., Metcalf, P. A., & Ley, S. J. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.619 · Cited by 240
Changes in incidence of diabetes in U.S. adults, 1997–2003
Geiss, L. S., Pan, L., Cadwell, B., Gregg, E. W., Benjamin, S. M., & Engelgau, M. M. (2006) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2005.12.009 · Cited by 229
Heidemann, C., Hoffmann, K., Spranger, J., Klipstein-Grobusch, K., Möhlig, M., Pfeiffer, A. F. H., & Boeing, H. (2005) · Diabetologia · doi:10.1007/s00125-005-1743-1 · Cited by 220
“Since impairment of glucose homeostasis increases the risk of type 2 diabetes development [19–21], we used HbA1c as one of the four response variables in the analysis.”
MethodCavaghan, M. K., Ehrmann, D. A., Byrne, M. M., & Polonsky, K. S. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119562 · Cited by 216
Utility of hemoglobin A1c in predicting diabetes risk
Edelman, D., Olsen, M. K., Dudley, T. K., Harris, A. C., & Oddone, E. Z. (2004) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2004.40178.x · Cited by 213
The Diabetes Prevention Program Outcomes Study Research Group; prepared on behalf of the DPPOS Research Group, Orchard, T. J., Temprosa, M., Barrett‐Connor, E., Fowler, S. E., Goldberg, R. B., Mather, K. J., Marcovina, S. M., Montez, M., Ratner, R. E., et al. (2013) · Diabetic Medicine · doi:10.1111/j.1464-5491.2012.03750.x · Cited by 214
Self-citationManagement of the Metabolic Syndrome and Type 2 Diabetes Through Lifestyle Modification
Magkos, F., Yannakoulia, M., Chan, J. L., & Mantzoros, C. S. (2009) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-080508-141200 · Cited by 211
“From the clinical standpoint, diabetes prevention is especially important for people at high risk of developing the disease, such as those with impaired glucose tolerance (64).”
BackgroundMetabolic and Inflammation Variable Clusters and Prediction of Type 2 Diabetes
Hanley, A. J. G., Festa, A., D’Agostino, R. B., Wagenknecht, L. E., Savage, P. J., Tracy, R. P., Saad, M. F., & Haffner, S. M. (2004) · Diabetes · doi:10.2337/diabetes.53.7.1773 · Cited by 198
Dietary cis-monounsaturated fatty acids and metabolic control in type 2 diabetes
Ros, E. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/78.3.617s · Cited by 192
Meigs, J. B., Nathan, D. M., Wilson, P. W. F., Cupples, L. A., & Singer, D. E. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-7-199804010-00002 · Cited by 192
“7% of persons with impaired glucose tolerance develop diabetes each year (9, 12-15).”
BackgroundResultGregg, E. W., Cheng, Y. J., Narayan, K. M. V., Thompson, T. J., & Williamson, D. F. (2007) · Preventive Medicine · doi:10.1016/j.ypmed.2007.07.020 · Cited by 185
“Cohort studies of diabetes incidence have provided a rich body of literature (Colditz et al., 1995; Edelstein et al., 1997; Ford et al., 1997; Leibson et al., 2001; Burke et al., 2003) on the association of BMI and diabetes and have shown, for example, that about half of incident diabetes cases are…”
BackgroundInfluentialThe Diabetes Prevention Program
(2002) · Controlled Clinical Trials · doi:10.1016/s0197-2456(01)00184-2 · Cited by 175
The role of physical activity in the management of impaired glucose tolerance: a systematic review
Yates, T., Khunti, K., Bull, F., Gorely, T., & Davies, M. J. (2007) · Diabetologia · doi:10.1007/s00125-007-0638-8 · Cited by 161
“Prediabetes is associated with an increased risk of development of type 2 diabetes [3] and cardiovascular disease [4–6].”
Women and Heart Disease: The Role of Diabetes and Hyperglycemia
Barrett-Connor, E., Giardina, E.-G. V., Gitt, A. K., Gudat, U., Steinberg, H. O., & Tschoepe, D. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.9.934 · Cited by 169
Self-citationAnalyzing milestones in smoking cessation: Illustration in a nicotine patch trial in adult smokers.
Shiffman, S., Scharf, D. M., Shadel, W. G., Gwaltney, C. J., Dang, Q., Paton, S. M., & Clark, D. B. (2006) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.74.2.276 · Cited by 168
Dietary Glycemic Index and Load and the Risk of Type 2 Diabetes: Assessment of Causal Relations
Livesey, G., Taylor, R., Livesey, H. F., Buyken, A. E., Jenkins, D. J. A., Augustin, L. S. A., Sievenpiper, J. L., Barclay, A. W., Liu, S., Wolever, T. M. S., et al. (2019) · Nutrients · doi:10.3390/nu11061436 · Cited by 163
“The routes from higher glycemia and higher free-fatty acids to the endpoints were established well over a decade ago [2,3,56] or even longer [57] and now provide targets for treatment strategies [4].”
Petersen, J. L., & McGuire, D. K. (2005) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2005.007 · Cited by 159
Williams, J. W., Zimmet, P. Z., Shaw, J. E., De Courten, M. P., Cameron, A. J., Chitson, P., Tuomilehto, J., & Alberti, K. G. M. M. (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.01059.x · Cited by 148
Azmi, S., Ferdousi, M., Petropoulos, I. N., Ponirakis, G., Alam, U., Fadavi, H., Asghar, O., Marshall, A., Atkinson, A. J., Jones, W., et al. (2015) · Diabetes Care · doi:10.2337/dc14-2733 · Cited by 148
Changes in BMI and Weight Before and After the Development of Type 2 Diabetes
Looker, H. C., Knowler, W. C., & Hanson, R. L. (2001) · Diabetes Care · doi:10.2337/diacare.24.11.1917 · Cited by 136
Self-citationIn Vivo Insulin Sensitivity and Secretion in Obese Youth
Bacha, F., Gungor, N., Lee, S., & Arslanian, S. A. (2009) · Diabetes Care · doi:10.2337/dc08-1030 · Cited by 90
“Impaired glucose tolerance is a well known prediabetic state with a linear relationship between the 2hr post challenge glucose levels and subsequent risk for T2DM in adult prospective studies (1) with observed rates of progression from IGT to T2DM from 20% (13) to 60% (14,15) over an average duration of 2 to 8 years (…”
BackgroundActos Now for the prevention of diabetes (ACT NOW) study
DeFronzo, R. A., Banerji, M., Bray, G. A., Buchanan, T. A., Clement, S., Henry, R. R., Kitabchi, A. E., Mudaliar, S., Musi, N., Ratner, R., et al. (2009) · BMC Endocrine Disorders · doi:10.1186/1472-6823-9-17 · Cited by 89
“In addition, they evaluated data sets from six population based cohorts [43].”
Johnson, S. L., Tabaei, B. P., & Herman, W. H. (2005) · Diabetes Care · doi:10.2337/diacare.28.2.307 · Cited by 73
van Genugten, R. E., Utzschneider, K. M., Tong, J., Gerchman, F., Zraika, S., Udayasankar, J., Boyko, E. J., Fujimoto, W. Y., Kahn, S. E., & and the American Diabetes Association GENNID Study Group (2006) · Diabetes · doi:10.2337/db06-0577 · Cited by 73
“While IFG and IGT both are known to increase the risk of developing diabetes, there are a number of other factors that also influence progression to hyperglycemia, including a family history of type 2 diabetes (22,23).”
BackgroundGlucose challenge test screening for prediabetes and undiagnosed diabetes
Phillips, L. S., Ziemer, D. C., Kolm, P., Weintraub, W. S., Vaccarino, V., Rhee, M. K., Chatterjee, R., Narayan, K. M. V., & Koch, D. D. (2009) · Diabetologia · doi:10.1007/s00125-009-1407-7 · Cited by 67
Long-term non-pharmacological weight loss interventions for adults with prediabetes
Norris, S. L., Zhang, X., Avenell, A., Gregg, E., Schmid, C. H., & Lau, J. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005270 · Cited by 60
Diabetes Prevention Program (DPP) Research Group, Hamman, R. F., Horton, E., Barrett-Connor, E., Bray, G. A., Christophi, C. A., Crandall, J., Florez, J. C., Fowler, S., Goldberg, R., et al. (2015) · Diabetes · doi:10.2337/db14-0333 · Cited by 46
“Men, n (%) 888 (32) 291 (32) 307 (33) 290 (31)”
BackgroundSelf-citationModest Lifestyle Intervention and Glucose Tolerance in Obese African Americans
Racette, S. B., Weiss, E. P., Obert, K. A., Kohrt, W. M., & Holloszy, J. O. (2001) · Obesity Research · doi:10.1038/oby.2001.45 · Cited by 46
Guo, F., & Garvey, W. T. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2691 · Cited by 44
“Elevated 2-hour glucose has previously been used in several diabetes prediction algorithms (16, 32).”
MethodLey, S. J., Metcalf, P. A., Scragg, R. K. R., & Swinburn, B. A. (2004) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2003.09.001 · Cited by 43
How effective are lifestyle changes in the prevention of type 2 diabetes mellitus?
Pi-Sunyer, F. X. (2008) · Nutrition Reviews · doi:10.1111/j.1753-4887.2007.tb00287.x · Cited by 40
“The conversion rate to diabetes has varied in differing population groups, but is about 5% to 6% per year.(4) IGT has been shown to be a risk factor for macrovascular disease(3,5) and also increases cardiovascular mortality.”
BackgroundLaparoscopic adjustable gastric banding and progression from impaired fasting glucose to diabetes
Wentworth, J. M., Hensman, T., Playfair, J., Laurie, C., Ritchie, M. E., Brown, W. A., Skinner, S., Shaw, J. E., & O’Brien, P. E. (2014) · Diabetologia · doi:10.1007/s00125-013-3129-0 · Cited by 16
“People with impaired fasting glucose (IFG) and/or impaired glucose tolerance (IGT) are at high risk of developing type 2 diabetes [2], and obesity increases the risk of progressing from IGT to diabetes [3, 4].”
Backgroundde Vegt, F., Dekker, J. M., Jager, A., Hienkens, E., Kostense, P. J., Stehouwer, C. D. A., Nijpels, G., Bouter, L. M., & Heine, R. J. (2001) · JAMA · doi:10.1001/jama.285.16.2109 · Cited by 10
“4% within 4 years(7) and for Pima Indians the cumulative incidence of diabetes was 62% within 7 years.(11) In Kinmen, a series of islands located in the Pacific Ocean, the cumulative incidence was 8.”
Background
Metadata
- Authors
- Edelstein, S. L., Knowler, W. C., Bain, R. P., Andres, R., Barrett-Connor, E. L., Dowse, G. K., Haffher, S. M., Pettitt, D. J., Sorkin, J. D., Muller, D. C., Collins, V. R., & Hamman, R. F.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 1997-04-01
- Volume
- 46
- Issue
- 4
- Pages
- 701-710
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2102264499
- Cited by
- 641
- References
- 41
- FWCI
- 7.96
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.